<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0004045" disease_type="Disease or Syndrome" abbrv="">Neonatal asphyxia</z:e> causes long-term neurological and behavioural impairment in the developing brain </plain></SENT>
<SENT sid="1" pm="."><plain>Concurrent administration of <z:chebi fb="3" ids="49957">xenon</z:chebi> and <z:hpo ids='HP_0002045'>hypothermia</z:hpo> synergistically reduces long-term damage in a rat model of <z:e sem="disease" ids="C0004045" disease_type="Disease or Syndrome" abbrv="">neonatal asphyxia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This study sought to investigate whether asynchronous administration of <z:chebi fb="3" ids="49957">xenon</z:chebi> and <z:hpo ids='HP_0002045'>hypothermia</z:hpo> is capable of combining synergistically to provide neuroprotection </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Seven-day-old rats were subjected to right common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 90 min <z:mp ids='MP_0005039'>hypoxia</z:mp> with 8% oxygen </plain></SENT>
<SENT sid="4" pm="."><plain>After a 1 h recovery period, rats received asynchronous administration of mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (35 degrees C) and <z:chebi fb="3" ids="49957">xenon</z:chebi> (20%) with a 1 or 5 h gap between interventions, <z:chebi fb="3" ids="49957">xenon</z:chebi> (20%) alone, or mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (35 degrees C) alone </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume in the brain was measured 4 days after injury </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Administration of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> or <z:chebi fb="3" ids="49957">xenon</z:chebi> alone, 1 and 6 h after the hypoxic ischaemic insult, respectively, provided no neuroprotection </plain></SENT>
<SENT sid="7" pm="."><plain>Asynchronous administration of <z:chebi fb="3" ids="49957">xenon</z:chebi> and <z:hpo ids='HP_0002045'>hypothermia</z:hpo> at a 1 h interval produced a significant reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume [93 (7) vs 74 (8); P &lt; 0.05] </plain></SENT>
<SENT sid="8" pm="."><plain>Reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was also present when <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and <z:chebi fb="3" ids="49957">xenon</z:chebi> were asynchronously administered with an intervening gap of 5 h [97 (5) vs 83 (3); P &lt; 0.05] </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This finding provides a rationale for investigating the combined use of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and <z:chebi fb="3" ids="49957">xenon</z:chebi> in a progressive manner for the management of <z:e sem="disease" ids="C0004045" disease_type="Disease or Syndrome" abbrv="">neonatal asphyxia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:hpo ids='HP_0002045'>hypothermia</z:hpo> can be administrated at the site of delivery and <z:chebi fb="3" ids="49957">xenon</z:chebi> can be administered later </plain></SENT>
</text></document>